As a tumor suppressor gene associated with cancer development, NF2 mutations are also observed in various other human malignancies, including melanoma, clear cell renal cell carcinoma, breast cancer, hepatobiliary cancer, glioblastoma, medullary thyroid carcinoma, and prostate cancer. Here, NF2 is linked to breast carcinoma.